Medreich Limited Nifedipine Export Data — India (DGFT 2022–2026)

Name: Medreich Limited Nifedipine Export Records India — #12 Exporter, 19 Shipments, $500.6K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Nifedipine

India Pharmaceutical Trade Intelligence

$30.1M331 Suppliers117 CountriesHS 30049072

ExportsIndia → UNITED STATES12.2%India → ZIMBABWE11.0%

ImportsUNITED STATES → India$36.0K CANADA → India$9.5K

#1 Supplier: CIPLA LIMITED #1 Buyer: ASCEND LABORATORIES,LLC

Medreich Limited — Nifedipine Exporter #12 | $500.6K Trade Value | TransData Nexus | TransData Nexus

Medreich Limited — Nifedipine Exporter Profile

Indian Pharmaceutical Exporter · #12 for Nifedipine · $500.6K export value · DGFT Verified

Medreich Limited is the #12 Indian exporter of Nifedipine with $500.6K in export value and 19 verified shipments. Medreich Limited holds a 1.7% market share in Nifedipine exports across 2 countries. The company exports 42 pharmaceutical products worth $224.8M across 15 therapeutic categories.

Medreich Limited — Nifedipine Export Profile: Buyers & Destinations

Medreich Limited Nifedipine export treemap — buyers and destination countries | TransData Nexus

Where Does Medreich Limited Export Nifedipine?

Country	Value	Shipments	Share
FRANCE	$376.0K	14	75.1%
PORTUGAL	$124.6K	5	24.9%

Medreich Limited exports Nifedipine to 2 countries. The largest destination is FRANCE accounting for 75.1% of Medreich Limited's Nifedipine shipments. These destinations reflect Medreich Limited's established distribution network and regulatory approvals in key markets.

Who Are the Top Buyers of Nifedipine from Medreich Limited?

Buyer

What Nifedipine Formulations Does Medreich Limited Export?

Product Description / Formulation	Value	Shipments
ATENOLOL 50 MG AND NIFEDIPINE 20MG CAPSU	$147.9K	8
ATENOLOL 50MG / NIFEDIPINE 20MG CAPSULES	$116.8K	3
ATENOLOL 50MG/NIFEDIPINE 20MG CAPSULES M	$76.1K	2
NIFEDIPINE 20MG TABLETS (NIFEDIPINA 20MGTABLETS) 6X10S (65328 PACKS)	$42.5K	1
NIFEDIPINE 20MG TABLETS (NIFEDIPINA 20MGTABLETS)6X10S (65633 PACKS)	$42.3K	1
NIFEDIPINE 20MG TABLETS (NIFEDIPINA 20MG	$39.2K	2
ATENOLOL 50MG AND NIFEDIPINE 20MG CAPSUL	$35.2K	1
NIFEDIPINE 20MG TABLETS(NIFEDIPINA 20MG	$662	1

Medreich Limited exports 8 distinct Nifedipine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ATENOLOL 50 MG AND NIFEDIPINE 20MG CAPSU with 8 shipments worth $147.9K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Medreich Limited Compare to Nearest Nifedipine Exporters?

Exporters ranked immediately above and below #12 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
10	TORRENT PHARMACEUTICALS LIMITED	$678.0K	31	7	$21.9K
11	MEDWISE OVERSEAS PRIVATE LIMITED	$646.9K	28	3	$23.1K
12	MEDREICH LIMITED ★	$500.6K	19	2	$26.3K
13	INNOVA CAPTAB LIMITED	$381.6K	54	3	$7.1K
14	BELCO PHARMA	$366.1K	27	2	$13.6K

Medreich Limited ranks #12 among 331 Indian Nifedipine exporters. Average shipment value of $26.3K compared to the market average of $67.5K. The closest competitors by value are TORRENT PHARMACEUTICALS LIMITED and MEDWISE OVERSEAS PRIVATE LIMITED.

Which Indian Ports Ship Nifedipine Exports?

Port	Shipments	% Share
SAHAR AIR	407	14.8%
NHAVA SHEVA SEA (INNSA1)	352	12.8%
SAHAR AIR CARGO ACC (INBOM4)	310	11.3%
JNPT/ NHAVA SHEVA SEA	194	7.1%
JNPT	172	6.3%
DELHI AIR	147	5.3%
DELHI AIR CARGO ACC (INDEL4)	145	5.3%
Bombay Air	82	3.0%

Geopolitical & Trade Policy Impact on Medreich Limited's Nifedipine Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Medreich Limited. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased shipping costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structures of exporters relying on these routes. (sgeexport.com)

Conversely, the US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of tariffs on pharmaceutical imports by the US poses a risk to Indian companies, as higher tariffs could render low-margin generic drugs unprofitable, leading to market exits and exacerbating drug shortages in the US. (cfo.economictimes.indiatimes.com)

The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a favorable development for Medreich. The FTA eliminates tariffs on Indian pharmaceutical products entering the EU, providing immediate cost relief and enhancing market access. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, creating new opportunities for companies like Medreich to expand their presence in the EU market. (en.wikipedia.org)

Medreich Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent quality requirements that companies must adhere to for market access. Recent regulatory frameworks have increased compliance costs by an average of 18.7%, leading to a 15.2% reduction in export volumes to the US in the first quarter of 2025. (transdatanexus.com)

For Medreich Limited, maintaining compliance with these evolving standards is crucial to sustaining and expanding its export markets. Investments in quality assurance, regular audits, and staying abreast of regulatory changes are essential strategies to navigate this complex landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Nifedipine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Medreich Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 19 individual customs records matching Medreich Limited exporting Nifedipine, covering 8 formulations to 2 countries via 4 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 117+ countries, 666+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Nifedipine

Nifedipine

Medreich Limited — Nifedipine Exporter Profile

Medreich Limited — Nifedipine Export Profile: Buyers & Destinations

Where Does Medreich Limited Export Nifedipine?

Who Are the Top Buyers of Nifedipine from Medreich Limited?

What Is India's Total Nifedipine Export Value and How Much Does Medreich Limited Contribute?

What Is the Average Shipment Value for Medreich Limited's Nifedipine Exports?

How Does Medreich Limited Compare to Other Indian Nifedipine Exporters?

What Nifedipine Formulations Does Medreich Limited Export?

How Does Medreich Limited Compare to Nearest Nifedipine Exporters?

Which Indian Ports Ship Nifedipine Exports?

Geopolitical & Trade Policy Impact on Medreich Limited's Nifedipine Exports

Medreich Limited — Regulatory Compliance & Quality Standards

About Medreich Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Nifedipine Export Data from Medreich Limited

Nifedipine Stats

Company Overview

Top Products by Medreich Limited

Related Analysis

Need Detailed Export Data?

Data Source

SUBSTIPHARM	FRANCE	$376.0K	14
FHC FARMACEUTICA LDA	PORTUGAL	$81.5K	3
FHC-FARMACEUTICA.LDA	PORTUGAL	$42.5K	1
FHC - FARMACEUTICA, LDA	PORTUGAL	$662	1